Global CNS Biomarker Market to Exceed USD 17.89 Billion by 2031, Fueled by Demand for Early Diagnosis and Precision Neurology
[Boston, 4th July 2025] – Clearview Market Insights (CVMI) reports that the global CNS
biomarker market will grow from USD 7.93 billion in 2024 to USD 17.89 billion
by 2031, with a CAGR of 12.3%. The market is driven by the increasing
prevalence of neurological disorders, rising demand for early diagnostics, and
advances in precision medicine in neuroscience.
“CNS biomarkers are transforming neurology by
facilitating early diagnosis, personalized therapies, and efficient disease
monitoring, especially in Alzheimer’s and Parkinson’s disease,” said Dr. Elena
Foster, neuroscience analyst at CVMI.
Request Sample @ https://clearviewmarketinsights.com/report-details/global-central-nervous-system-cns-biomarker-market/
Key Market Highlights
- 2024
Market Size: USD 7.93 billion
- 2031
Forecast: USD 17.89 billion
- CAGR:
12.3% (2024–2031)
Growth Catalysts
- Rise
in neurological disorders: Alzheimer's, Parkinson's, MS driving biomarker
demand.
- Precision
Medicine: Tailoring treatments based on biomarker insights.
- Advancements
in Omics & Imaging: Growth in liquid biopsy and AI-driven biomarker
discovery.
Segment Insights
- Top Biomarker Type: Diagnostic biomarkers account for over 40% of
the share.
- Fastest-Growing Application: Monitoring drug discovery and clinical
trials.
- Regional Leaders: North America leads, followed by Europe; APAC is
the fastest-growing region.
Competitive Overview (2024)
- Thermo
Fisher – 20%: Leader in omics-based CNS biomarker assays.
- Bio-Rad
– 17%: Robust portfolio in multiplex and neurodegenerative biomarkers.
- Merck
– 15%: Focus on proteomics and neurodegeneration kits.
- Others
– 48%: Mix of imaging, omics, and assay providers globally.
Outlook to 2031
The CNS biomarker market will keep growing
with the development of AI-integrated biomarker platforms, portable diagnostic
devices, and liquid biopsy solutions for neurological diseases. Growth in
emerging markets will be driven by increased investments in neuroscience and
healthcare infrastructure.
For more insights, visit https://clearviewmarketinsights.com/
About Clearview Market Insights:
Clearview Market Insights is a leading
market research and consulting firm providing in-depth industry analysis and
strategic recommendations for businesses worldwide.
Media contact:
Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369
Comments
Post a Comment